Therefore, the widely accepted tumor suppressor activity of CEACAM1-L in PCa should be reevaluated by analyzing different PCa cell lines, considering factors such as androgen sensitivity, neuroendocrine characteristics, and the given CEACAM1-S/CEACAM1-L ratio. The gene discussed is CEACAM1; the disease is neoplasm.